Insight Molecular Diagnostics Inc. filed corrected Third Amended and Restated Bylaws as Exhibit 3.1 to rectify a clerical error in its March 26, 2026 Form 10-K, confirming no changes to other 10-K disclosures.
Key takeaways
Company filed Annual Report on Form 10-K for year ended December 31, 2025 on March 26, 2026.
10-K Exhibit 3.5 inadvertently included shareholder voting provisions not part of the Bylaws due to clerical error.
Correct Bylaws filed as Exhibit 3.1 with this 8-K.
Bylaws govern offices, shareholder meetings, nominations, and proposals.
No changes to any other Form 10-K disclosures.
Special shareholder meetings callable by board, Chair, President, or 10% voting shareholders.